Back to today’s briefing

Story perspectives

FDA Approves Vykat XR: Hope for Prader-Willi Syndrome

6/17/2025

36 5

Summary

Story summary

Dean Shenk, living with Prader-Willi syndrome, faced relentless hunger until the FDA's approval of Vykat XR changed everything. This groundbreaking medication has liberated him from food fixation, opening doors to new passions. While its price tag is steep, researchers are optimistic that it will pave the way for advancements in obesity treatment and understanding.

1 of 1

Story summary

Dean Shenk, living with Prader-Willi syndrome, faced relentless hunger until the FDA's approval of Vykat XR changed everything. This groundbreaking medication has liberated him from food fixation, opening doors to new passions. While its price tag is steep, researchers are optimistic that it will pave the way for advancements in obesity treatment and understanding.